Manouchehr Iranparvar-Alamdari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Manouchehr Iranparvar-Alamdari has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Abdolreza Shaghaghi
Department of Health Education and Promotion, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
1 shared publication - Afrouz Mardi
Department of public Health, school of health, Ardabil university of medical science, Ardabil, Iran
1 shared publication - Ali Tarighat-Esfanjani
Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication - Arezoo Haghighian Roudsari
Department of Community Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication - Daniel Hackett
The University of Sydney
1 shared publication - Maryam Rafraf
Nutrition Research Center, Department of Community Nutrition, Faculty of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication
Latest Publications
- Open Access
- 17 January 2025
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 25, 1-10
Effect of a Medication Adherence Education Intervention on Clinical Outcomes in Adults with Type 2 Diabetes Mellitus: A Randomized Controlled Trial Study
: Background: Low adherence to Oral Antidiabetic Drugs (OADs) in adults with Type 2Diabetes Mellitus (T2DM) leads to complications, death, and increased healthcare costs. Objective: This study aimed to evaluate the effectiveness of medication adherence education interventionsfor the clinical outcomes of adults with T2DM. Materials and Methods: Seventy adults with T2DM from an outpatient clinic in the City of Ardabil,Iran, participated in this study. The participants were randomized into an intervention group(n=35) or a non-interventional group (n=35). The intervention group underwent four educationalsessions focused on adherence to OADs. Content within classes was influenced by a participant'sStage of Change (SOC) result, which was related to behavior change modeling. Participants in thenon-interventional group were placed on a waiting list to receive educational content after the follow-up. Assessments were conducted at baseline, four weeks, and six months. Results: Significant improvements in Fasting Plasma Glucose (FPG) (P = 0.018) and 2-hour PlasmaGlucose (2-hPG) (P < 0.001) levels were found in the intervention group compared to the noninterventionalgroup post-intervention. Additionally, HbA1C was significantly lower at follow-upin the intervention group than in the non-intervention group (P < 0.001). The Homeostasis Modelof Insulin Resistance Assessment (HOMA-IR) revealed a significant increase in target cell sensitivityto insulin in the intervention group compared to that in the non-interventional during the follow-up period (P = 0.009). The SOC for adherence to OADs was significantly improved in the interventiongroup compared to that in the non-intervention group at the follow-up timepoint (P<0.001). Conclusion: Medication adherence education interventions may improve the clinical outcomes ofadults with T2DM.
- 17 January 2025
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 25, 1-10
Open AccessEffect of a Medication Adherence Education Intervention on Clinical Outcomes in Adults with Type 2 Diabetes Mellitus: A Randomized Controlled Trial Study
: Background: Low adherence to Oral Antidiabetic Drugs (OADs) in adults with Type 2Diabetes Mellitus (T2DM) leads to complications, death, and increased healthcare costs. Objective: This study aimed to evaluate the effectiveness of medication adherence education interventionsfor the clinical outcomes of adults with T2DM. Materials and Methods: Seventy adults with T2DM from an outpatient clinic in the City of Ardabil,Iran, participated in this study. The participants were randomized into an intervention group(n=35) or a non-interventional group (n=35). The intervention group underwent four educationalsessions focused on adherence to OADs. Content within classes was influenced by a participant'sStage of Change (SOC) result, which was related to behavior change modeling. Participants in thenon-interventional group were placed on a waiting list to receive educational content after the follow-up. Assessments were conducted at baseline, four weeks, and six months. Results: Significant improvements in Fasting Plasma Glucose (FPG) (P = 0.018) and 2-hour PlasmaGlucose (2-hPG) (P < 0.001) levels were found in the intervention group compared to the noninterventionalgroup post-intervention. Additionally, HbA1C was significantly lower at follow-upin the intervention group than in the non-intervention group (P < 0.001). The Homeostasis Modelof Insulin Resistance Assessment (HOMA-IR) revealed a significant increase in target cell sensitivityto insulin in the intervention group compared to that in the non-interventional during the follow-up period (P = 0.009). The SOC for adherence to OADs was significantly improved in the interventiongroup compared to that in the non-intervention group at the follow-up timepoint (P<0.001). Conclusion: Medication adherence education interventions may improve the clinical outcomes ofadults with T2DM.